相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The mTOR inhibitor everolimus attenuates tacrolimus-induced renal interstitial fibrosis in rats
Tomohiro Shigematsu et al.
LIFE SCIENCES (2022)
Autophagy inhibition attenuates TGF-β2-induced epithelial-mesenchymal transition in lens epithelial cells
Yan Sun et al.
LIFE SCIENCES (2021)
The Role of TNF-α and Anti-TNF-α Agents during Preconception, Pregnancy, and Breastfeeding
Katarzyna Romanowska-Prochnicka et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Impaired ATG16L-Dependent Autophagy Promotes Renal Interstitial Fibrosis in Chronic Renal Graft Dysfunction Through Inducing EndMT by NF-κB Signal Pathway
Zeping Gui et al.
FRONTIERS IN IMMUNOLOGY (2021)
Guidelines and definitions for research on epithelial-mesenchymal transition
Jing Yang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
The Impact of Everolimus and Radiation Therapy on Pulmonary Fibrosis
Mehmet Fuat Eren et al.
MEDICINA-LITHUANIA (2020)
AMPK/mTOR Signaling in Autophagy Regulation During Cisplatin-Induced Acute Kidney Injury
Ying Wang et al.
FRONTIERS IN PHYSIOLOGY (2020)
The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders
Jacopo Di Gregorio et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Everolimus reduces postoperative arthrofibrosis in rabbits by inducing autophagy-mediated fibroblast apoptosis by PI3K/Akt/mTOR signaling pathway
Yun Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Bortezomib attenuates renal interstitial fibrosis in kidney transplantation via regulating the EMT induced by TNF-α-Smurf1-Akt-mTOR-P70S6K pathway
Jiajun Zhou et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Autophagy inhibition-mediated epithelial-mesenchymal transition augments local myofibroblast differentiation in pulmonary fibrosis
Charlotte Hill et al.
CELL DEATH & DISEASE (2019)
Role of tumor necrosis factor-α in epithelial-to-mesenchymal transition in transplanted kidney cells in recipients with chronic allograft dysfunction
Chunchun Zhao et al.
GENE (2018)
Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation
Jun Li et al.
KIDNEY INTERNATIONAL (2018)
Cardiac repair by epicardial EMT: Current targets and a potential role for the primary cilium
Jessica N. Blom et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Vimentin expression is required for the development of EMT-related renal fibrosis following unilateral ureteral obstruction in mice
Zheng Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2018)
Role of endothelial-to-mesenchymal transition induced by TGF-β1 in transplant kidney interstitial fibrosis
Zijie Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
Transplantation: Survival benefit of accepting a diabetic deceased donor kidney
Ellen F. Carney
Nature Reviews Nephrology (2017)
Outcome of kidney transplant in primary, repeat, and kidney-after-nonrenal solid-organ transplantation: 15-year analysis of recent UNOS database
A. El-Husseini et al.
CLINICAL TRANSPLANTATION (2017)
30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology
Qian Zhang et al.
CELL (2017)
Continuous administration of the mTORC1 inhibitor everolimus induces tolerance and decreases autophagy in mice
Ammar Kurdi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
TGF-β: the connecting link between nephropathy and fibrosis
Brijesh Sutariya et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2016)
Autophagy links β-catenin and Smad signaling to promote epithelial-mesenchymal transition via upregulation of integrin linked kinase
Min Pang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation
Paola Tomei et al.
JOURNAL OF NEPHROLOGY (2016)
Acute and Chronic Allograft Dysfunction in Kidney Transplant Recipients
Ryan J. Goldberg et al.
MEDICAL CLINICS OF NORTH AMERICA (2016)
Everolimus restrains the paracrine pro-osteoclast activity of breast cancer cells
Valeria Simone et al.
BMC CANCER (2015)
Epithelial to mesenchymal transition in the liver field: the double face of Everolimus in vitro
Valentina Masola et al.
BMC GASTROENTEROLOGY (2015)
TNF receptors: signaling pathways and contribution to renal dysfunction
Rafia S. Al-Lamki et al.
KIDNEY INTERNATIONAL (2015)
Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study
Lutz Fischer et al.
TRANSPLANTATION (2015)
Renal function three years after early conversion from a calcineurin inhibitor to everolimus: results from a randomized trial in kidney transplantation
Lars Mjornstedt et al.
TRANSPLANT INTERNATIONAL (2015)
New insights regarding chronic antibody-mediated rejection and its progression to transplant glomerulopathy
Carrie A. Schinstock et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2014)
Xenon Treatment Protects Against Cold Ischemia Associated Delayed Graft Function and Prolongs Graft Survival in Rats
H. Zhao et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Targeting mTOR Pathways in Human Malignancies
Angelica Fasolo et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Involvement of autophagy in the pharmacological effects of the mTOR inhibitor everolimus in acute kidney injury
Shunsaku Nakagawa et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Early treatment with everolimus exerts nephroprotective effect in rats with adriamycin-induced nephrotic syndrome
Rawi Ramadan et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Autophagosomal IκBα Degradation Plays a Role in the Long Term Control of Tumor Necrosis Factor-α-induced Nuclear Factor-κB (NF-κB) Activity
Amy Colleran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells
Ma'anit Shapira et al.
BREAST CANCER RESEARCH (2006)
Growing roles for the mTOR pathway
DD Sarbassov et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
分享论文
